Industry stakeholders were generally optimistic about proposed data-exchange rules, but they want regulators to ensure the information is useful to patients and clinicians.
Industry stakeholders were generally optimistic about proposed data-exchange rules, but they want regulators to ensure the information is useful to patients and clinicians.